Vallon Pharmaceuticals (NASDAQ:VLON) will report on Q2 2021.
SVB Leerink Maintains Outperform on Acadia Healthcare Co, Raises Price Target to $95
SVB Leerink maintains Acadia Healthcare Co (NASDAQ:ACHC) with a Outperform and raises the price target from $90 to $95.